Stay updated on Nivolumab and Plinabulin in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Plinabulin in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Plinabulin in NSCLC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-05T19:28:42.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:25:10.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    - Revision label updated from v3.4.0 to v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-04T23:42:59.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a glossary section and updated metadata labels, including 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while older labels such as 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' were removed or adjusted. These changes do not affect the study details, eligibility criteria, or primary outcomes — To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T20:06:36.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision note updated from v3.3.3 to v3.3.4; no substantive study information appears to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:45:19.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Added a new Locations section showing California as a location (UC San Diego Moores Cancer Center). Removed the California Locations label and the HHS Vulnerability Disclosure, and updated the revision from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T22:12:25.000Z thumbnail image

Stay in the know with updates to Nivolumab and Plinabulin in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Plinabulin in NSCLC Clinical Trial page.